AXALBION
Axalbion is a pharmaceutical company that develops and eveluates RPM8 agonists
AXALBION
Social Links:
Industry:
Biotechnology Health Care
Founded:
2017-01-01
Address:
Lausanne, Vaud, Switzerland
Country:
Switzerland
Website Url:
http://www.axalbion.com
Status:
Active
Email Addresses:
[email protected]
Technology used in webpage:
Google Maps Google Maps API Google Maps For Work Swiss Server Location
Similar Organizations
Alpha-5 Integrin
Alpha-5 Integrin is a privately held preclinical-stage company that is developing monoclonal antibodies.
Hexagen
Hexagen is a pharmaceutical company, manufacturing quality pharma products to customers.
Kupando
Kupando is a biopharmaceutical company that develops agonists to stimulates innate immunity.
Ursa Bio
Ursa Bio is an aerospace medicine company that helps in solving health issues in astronauts during prolonged spaceflight.
Current Employees Featured
Official Site Inspections
http://www.axalbion.com
- Host name: h2web406.infomaniak.ch
- IP address: 185.125.27.25
- Location: Switzerland
- Latitude: 47.1449
- Longitude: 8.1551
- Timezone: Europe/Zurich
More informations about "Axalbion"
Axalbion
Axalbion is a clinical-stage pharmaceutical company developing TRPM8 agonists for the treatment of chronic cough and dry eyes, two chronic, common and debilitating disorders, with limited treatment options.See details»
Axalbion - Crunchbase Company Profile & Funding
Axalbion is a pharmaceutical company that develops and eveluates RPM8 agonistsSee details»
Axalbion Therapeutics Limited - LinkedIn
Axalbion is a clinical-stage pharmaceutical company developing TRPM8 agonists for the treatment of chronic cough and dry eyes, two chronic, common and debilitating disorders, with unmet needs and ...See details»
Axalbion 2025 Company Profile: Valuation, Funding & Investors
Information on valuation, funding, cap tables, investors, and executives for Axalbion. Use the PitchBook Platform to explore the full profile.See details»
AXALBION THERAPEUTICS LIMITED overview - Find and update …
AXALBION THERAPEUTICS LIMITED - Free company information from Companies House including registered office address, filing history, accounts, annual return, officers, charges, …See details»
Axalbion SA Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Axalbion SA of Lausanne, VAUD. Get the latest business insights from Dun & Bradstreet.See details»
Axalbion SA - Swiss Biotech
Axalbion is a clinical-stage pharmaceutical company developing TRPM8 agonists for the treatment of chronic cough. Axalbion’s s strategy is to develop its lead compound AX-8 up-to …See details»
Axalbion - VentureRadar
"Axalbion has synthesized and examined new TRPM8 agonists, identifying its lead candidate AX-8. Axalbion is a clinical-stage pharmaceutical company developing TRPM8 agonists for the …See details»
Axalbion - Profiles & Contacts - Crunchbase
Axalbion is a pharmaceutical company that develops and eveluates RPM8 agonistsSee details»
Management and Board of Directors - Axalbion
Dr. Kitt joined Axalbion as Chief Executive Officer in November 2019, bringing more than 30 years of clinical development experience and industry expertise. Prior to joining Axalbion he was the CEO of Attenua. He has been responsible …See details»
Axalbion Therapeutics Announces First Patient Dosed in Phase 2 …
Aug 27, 2024 Manchester, UK and Mountain View, Calif, August 27, 2024 – Axalbion, a clinical-stage biopharmaceutical company focused on developing novel medicines to treat cough, …See details»
News - Axalbion
Oct 20, 2021 Axalbion Therapeutics Announces First Patient Dosed in Phase 2 Clinical Study in Chronic Cough with AX-8, a Novel TRPM8 Agonist; Proof-of-Concept Study with AX-8 …See details»
Pipeline : Axalbion
One Drug Candidate for Several Therapeutic Applications Axalbion has developed and evaluated new patented TRPM8 agonists. Biological testing was performed …See details»
Axalbion SA - startup.ch
Axalbion SA: Axalbion is a clinical-stage pharmaceutical company developing TRPM8 agonists for the treatment of chronic cough and dry eyes, two chronic, common and debilitating disorders, …See details»
Axalbion SA - MedPath
Phase 2 Recruiting Conditions Chronic Cough Interventions Drug: AX-8, Part 1 of the study Drug: AX-8, Part 2 of the study Drug: Placebo, Part 1 of the study Drug: Placebo, Part 2 of the study …See details»
Axalbion SA - BioAlps
Clinical-stage pharmaceutical company developing TRPM8 agonists for the treatment of chronic cough and dry eyes, two chronic, common and debilitating disorders, with limited treatment …See details»
Axalbion - Contacts, Employees, Board Members, Advisors & Alumni
Axalbion is a pharmaceutical company that develops and eveluates RPM8 agonistsSee details»
Axalbion - Tech Stack, Apps, Patents & Trademarks - Crunchbase
May 11, 2025 Axalbion is ranked 15,424,720 among websites globally based on its 139 monthly web visitors. Site's traffic by country:See details»
Contact - Axalbion
Please contact us if you need further information about the company or its products at [email protected]. If you are interested in investing in our company, please contact us at …See details»
Partners : Axalbion
The Management Team is building Axalbion’s clinical product portfolio around multiple collaborations – world leading experts as advisors and reputable strategic partners – …See details»